![](http://www.mobergpharma.com/sites/default/files/toppbild-partners-1551x278.jpg)
ABOUT MOB-015
Moberg Pharma’s goal is to make MOB-015 the leading treatment for nail fungus globally. MOB-015 is currently approved in ten European countries. Approvals are expected in three additional European countries. MOB-015 is available in Sweden under the brand name Terclara®